An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (doxercalciferol capsules) in Pediatric Patients with Chronic Kidney Disease Stages 3 and 4 with Secondary Hyperparathyroidism Not Yet on Dialysis
Clinical Trial Grant
Administered By
Pediatrics, Nephrology
Awarded By
Sanofi US
Start Date
November 19, 2018
End Date
December 31, 2022
Administered By
Pediatrics, Nephrology
Awarded By
Sanofi US
Start Date
November 19, 2018
End Date
December 31, 2022